São Paulo, November 2020 – Eurofarma, a Brazilian multinational present in 20 Latin American countries, living by its belief in appreciating the Brazilian medical community, has expanded its support project for resident doctors and launched a distance learning platform, whose goal is to bring quality information and contribute to the daily work of these healthcare professionals.

Through the www.amigoresidenteeurofarma.com.br website, residents will have access to courses, medical lectures, webinars, articles, podcasts, scientific journals, and other high-quality content developed by universities, professors, and partner institutions. Doctors need to inform their CRM (Regional Council of Medicine) number in a brief registration process to have access to the materials.

“Four years ago, Eurofarma started an exclusive program for residents, providing, during face-to-face visits, information about drugs, correct indications, drug interactions, among others. With the release of the platform, we take an important step to share knowledge and support the training of these professionals, who lead extremely busy lives between studies and shifts,” Roberta Junqueira, Commercial Director of Eurofarma, said.

The theme chosen for the launch of the platform was mental health, a discipline that gained even more notoriety with the impacts caused by the coronavirus pandemic. The four-module course “Psychopharmacology of Mental Disorders” was developed in partnership with the Centro de Estudos Paulista de Psiquiatria [Paulista Center for Psychiatric Studies], which brings together doctors from the Department of Psychiatry of the Paulista School of Medicine of the Federal University of São Paulo (Unifesp). The first module, called Mood Disorders, will be taught on November 26, starting at 7 p.m., and will address the following topics: Neurobiology of Depression, Bipolar Disorder, and Suicide Risk. Psychiatrist Jair Mari will coordinate the works, which will also include psychiatrists José Alberto Del Porto and Elson Asevedo, all from Unifesp. Registration is free and available directly on the project website.

Service
Psychopharmacology of Mental Disorders
Module 1: Mood Disorders – Neurobiology of Depression, Bipolar Disorder, and Suicide Risk
Date: November 26 | 7 p.m.
Registration and course: www.amigoresidenteeurofarma.com.br

About Eurofarma Group 
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.

EUROFARMA ON SOCIAL MEDIA
www.eurofarma.com.br
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarmalab | Twitter: @eurofarmaLab